Jakobsen A - Search Results

1

Oral fluoropyrimidines in the treatment of advanced colorectal cancer--results of two consecutive phase II trials.

Adimi P, Hansen F, Kjaer M, Aabo K, Keldsen N, Pfeiffer P, Sandberg E, Jakobsen A. Adimi P, et al. Among authors: jakobsen a. Acta Oncol. 2002;41(2):202-3. doi: 10.1080/028418602753669625. Acta Oncol. 2002. PMID: 12102169 Clinical Trial. No abstract available.

2

Dose-effect relationship of bolus 5-fluorouracil in the treatment of advanced colorectal cancer.

Jakobsen A, Berglund A, Glimelius B, Frödin JE, Hansen F, Kjaer M, Madsen EL, Sandberg E, Poulsen JP, Carlsson G, Gustavsson B; Nordic Gastrointestinal Tumour Therapy Group, Norway, Sweden and Denmark. Jakobsen A, et al. Acta Oncol. 2002;41(6):525-31. doi: 10.1080/02841860214959. Acta Oncol. 2002. PMID: 12546525 Clinical Trial.

3

A phase II study of UFT and Leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer.

Gyldenkerne N, Glimelius B, Frödin JE, Kjaer M, Pfeiffer P, Hansen F, Keldsen N, Sandberg E, Jakobsen A. Gyldenkerne N, et al. Among authors: jakobsen a. Acta Oncol. 2004;43(3):276-9. doi: 10.1080/02841860410028655. Acta Oncol. 2004. PMID: 15244251 Clinical Trial.

4

Dual modulation of UFT with leucovorin and hydroxyurea in metastatic colorectal cancer.

Jakobsen A, Pfeiffer P, Hansen F, Sandberg E, Aabo K. Jakobsen A, et al. Acta Oncol. 2001;40(1):63-6. doi: 10.1080/028418601750071073. Acta Oncol. 2001. PMID: 11321663 Clinical Trial.

5

Oral idarubicin in the treatment of advanced breast cancer.

Bastholt L, Dalmark M, Jakobsen A, Gadeberg CC, Sandberg E, Mouridsen HT. Bastholt L, et al. Among authors: jakobsen a. Acta Oncol. 1989;28(6):893-7. doi: 10.3109/02841868909092327. Acta Oncol. 1989. PMID: 2611039

6

Patient preference for oral or intravenous chemotherapy: a randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer.

Pfeiffer P, Mortensen JP, Bjerregaard B, Eckhoff L, Schønnemann K, Sandberg E, Aabo K, Jakobsen A. Pfeiffer P, et al. Among authors: jakobsen a. Eur J Cancer. 2006 Nov;42(16):2738-43. doi: 10.1016/j.ejca.2006.06.027. Epub 2006 Sep 29. Eur J Cancer. 2006. PMID: 17011184 Clinical Trial.

7

Weekly oral idarubicin in postmenopausal women with advanced breast cancer. A phase II study.

Bastholt L, Dalmark M, Jakobsen A, Gadeberg CC, Sandberg E, Mouridsen HT. Bastholt L, et al. Among authors: jakobsen a. Acta Oncol. 1990;29(2):143-6. doi: 10.3109/02841869009126534. Acta Oncol. 1990. PMID: 2334567

8

Blood natural killer cells during treatment in recurrent ovarian cancer.

Henriksen JR, Nederby L, Donskov F, Waldstrøm M, Adimi P, Jakobsen A, Dahl Steffensen K. Henriksen JR, et al. Among authors: jakobsen a. Acta Oncol. 2020 Nov;59(11):1365-1373. doi: 10.1080/0284186X.2020.1791358. Epub 2020 Jul 21. Acta Oncol. 2020. PMID: 32692270

9

Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study.

Keldsen N, Havsteen H, Vergote I, Bertelsen K, Jakobsen A. Keldsen N, et al. Among authors: jakobsen a. Gynecol Oncol. 2003 Feb;88(2):118-22. doi: 10.1016/s0090-8258(02)00103-8. Gynecol Oncol. 2003. PMID: 12586589 Clinical Trial.

10

Delta tocotrienol in recurrent ovarian cancer. A phase II trial.

Thomsen CB, Andersen RF, Steffensen KD, Adimi P, Jakobsen A. Thomsen CB, et al. Among authors: jakobsen a. Pharmacol Res. 2019 Mar;141:392-396. doi: 10.1016/j.phrs.2019.01.017. Epub 2019 Jan 9. Pharmacol Res. 2019. PMID: 30639384 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

541 results

Search Page